ClearPoint Neuro, Inc. Annual report pursuant to section 13 and 15(d)

Annual report pursuant to section 13 and 15(d)

Note 3 - Inventory

Note 3 - Inventory

12 Months Ended

Dec. 31, 2012

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

3. Inventory

Inventory consists of the following as of December 31:

	2012		2011
Work in process	$	494,290	$	454,366
Software license inventory		344,500		467,000
Finished goods		60,912		47,452
Inventory included in current assets		899,702		968,818
Software license inventory (see Note 10)		1,137,500		-
	$	2,037,202	$	968,818

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References + Details